Last 22 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.56 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 4.48 | 6.09 | 73.62 | 29.62 | 20.55 | 5.52 | 12.21 | 35.61 | 64.01 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | +10.5% | +503.1% | -16.8% | -67.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 3.74 | 3.49 | 19.93 | 4.78 | 1.31 | 2.23 | 25.32 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | +56.3% | -21.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 95.7% | 91.2% | 90.7% | 97.1% | 92.3% | 92.0% | 100.0% | 100.0% | 100.0% | — | — | — | — | — | — | — | — | — | — | — | — |
| — | -0.9% | -9.3% | -2.9% | -7.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | -986.6% | -616.4% | -727.9% | -718.1% | -1955.7% | -519.5% | -1304.4% | -7114.9% | -6552.9% | — | — | — | — | — | — | — | — | — | — | — | — |
| — | -18.7% | +44.2% | +89.9% | +70.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | -984.6% | -606.5% | -711.3% | -691.4% | -1897.3% | -592.3% | -1287.4% | -6595.5% | -6585.3% | — | — | — | — | — | — | — | — | — | — | — | — |
| — | -2.4% | +44.7% | +89.5% | +71.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -295.2% | -64.2% | -39.7% | -26.5% | -46.9% | -102.5% | -667.6% | — | — | — | — | — | — | — | — | — | — | — | — | -2.6% | -1.3% |
| — | +37.3% | +94.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| ROA | -129.1% | -37.5% | -27.7% | -19.6% | -29.0% | -25.1% | -61.6% | -95.6% | -111.2% | -57.7% | -225.7% | -342.9% | -315.7% | -85.6% | -220.9% | -406.4% | -150.3% | -97.4% | -195.0% | -2.3% | -1.1% |
| — | -49.5% | +55.0% | +79.5% | +73.9% | +56.6% | +72.7% | +72.1% | +64.8% | +32.5% | -2.1% | +15.6% | -110.0% | +12.2% | -13.3% | -17718.0% | -13147.9% | -9296.0% | -19455.8% | — | — | |
| ROIC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -1.7% | -0.9% |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.05 | — | 0.05 | 0.05 | — | — | 0.64 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | -93.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.63 | 1.89 | 2.73 | 3.63 | 3.66 | 1.52 | 0.96 | 0.55 | 0.54 | 0.24 | 0.68 | 0.18 | 0.18 | 0.17 | 0.42 | 0.09 | 0.38 | 0.37 | 0.12 | 0.19 | 2.25 |
| — | +24.6% | +182.6% | +559.2% | +571.5% | +523.9% | +42.4% | +211.2% | +201.6% | +43.7% | +60.9% | +88.1% | -52.1% | -54.2% | +263.5% | -51.2% | -83.3% | -92.5% | -97.3% | — | — | |
| Quick Ratio | 3.61 | 1.87 | 2.71 | 3.61 | 3.64 | 1.50 | 0.96 | 0.55 | 0.54 | 0.24 | 0.68 | 0.18 | 0.18 | 0.17 | 0.42 | 0.09 | 0.38 | 0.37 | 0.12 | 0.19 | 2.25 |
| — | +24.7% | +182.9% | +556.0% | +567.8% | +517.6% | +41.5% | +211.2% | +201.6% | +43.7% | +60.9% | +88.1% | -52.1% | -54.2% | +263.5% | -51.2% | -83.3% | -92.5% | -97.3% | — | — | |
| Interest Coverage | -37.01 | -465.25 | -600.50 | -222.38 | — | -6.49 | -341.64 | -17.47 | -15.46 | -38.43 | -87.79 | -48.65 | -31.29 | -9.85 | -15.39 | -52.49 | -14.37 | -3.72 | -4.94 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 22 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ICU stock.
SeaStar Medical Holding Corporation's current P/E is -0.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
SeaStar Medical Holding Corporation's current operating margin is -986.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking SeaStar Medical Holding Corporation's business trajectory between earnings reports.